In Europe, per year more than 100 000 new cases of melanoma are diagnosed.
Traditional therapies alone (surgery, radiotherapy, chemotherapy) are not effective once the disease has spread. Novel break-through therapies have revolutionized the treatment landscape, providing hope for long-term survival in advanced melanoma.
Recruiting advanced melanoma patients in a competitive melanoma clinical trials landscape is challenging.
Akcelis was asked to design and implement a multilingual recruitment strategy by creating awareness about the clinical trial.
Akcelis launched a multichannel patient awareness strategy: